Most GLP-1 drugs were initially approved by the FDA to treat Type 2 diabetes
Weve seen what that looks like with compounded GLP-1s and the harm that has come with it the hospitalizations, contaminated products, and in some cases, death, PCAC cannot allow peptides to follow that same path. I don't understand how MAHA can scream about "gold standard" clinical trials for vaccines, but push for the approval of synthetic peptides without proper clinical trials
2007 Sep;28(9):1960-4
They discovered that the interaction between endogenous GLP-1 and its receptors in the NST, but not AP, is vital for weight loss
This chronic inflammation drives fatigue, joint pain, muscle aches, brain fog, and mood disturbances that go far beyond simple thyroid hormone deficiency
How we reviewed this article: Helimeds has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations